Updates

Nath Bio-Genes reported a 14.5% YoY revenue increase to INR 49.4 Cr in Q4 and an 8.9% rise to INR 362.3 Cr for FY25. Gross profit improved by 7.1% YoY in Q4, reaching INR 33.8 Cr with a strong margin of 62.8%. However, Q4 EBITDA dropped 29.4% YoY to INR 3.2 Cr.

Profits from ordinary business surged 84.5% in Q4 to INR 4.2 Cr.

The company is diversifying beyond cotton and enhancing its position in vegetables, maize, and wheat, driving substantial growth and shareholder value.